Rx Propellant commits $100 million to build India's largest life sciences campus in Hyderabad
Rx Propellant, India’s leading science and R&D infrastructure platform established by Actis and part of General Atlantic, plans to invest $100 million to develop a large-format life sciences campus in Genome Valley, Hyderabad.
The development will deliver over one million square feet of advanced laboratory infrastructure in phases over the next six years. The first phase of the proposed campus will be completed by 2028.
The development will deliver over one million square feet of advanced laboratory infrastructure in phases over the next six years. The first phase of the proposed campus will be completed by 2028.
Next Story